LymphedemaV1, PubMed, Corpus, bibRecord, 000648

Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Identifieur interne : 000648 ( PubMed/Corpus ); précédent : 000647; suivant : 000649

Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Auteurs : Eileen Stillwaggon ; Larry Sawers ; Jonathan Rout ; David Addiss ; Leanne Fox

Source :

The American journal of tropical medicine and hygiene [ 1476-1645 ] ; 2016.

RBID : pubmed:27573626

English descriptors

KwdEn :
- Adolescent, Adult, Aged, Child, Chronic Disease, Community Health Services (economics), Community Health Services (methods), Cost-Benefit Analysis, Efficiency, Elephantiasis, Filarial (complications), Elephantiasis, Filarial (economics), Elephantiasis, Filarial (epidemiology), Endemic Diseases (economics), Female, Health Expenditures, Humans, India (epidemiology), Lymphedema (economics), Lymphedema (epidemiology), Lymphedema (etiology), Lymphedema (therapy), Male, Middle Aged, Sick Leave, Young Adult.
MESH :
- complications : Elephantiasis, Filarial.
- economics : Community Health Services, Elephantiasis, Filarial, Endemic Diseases, Lymphedema.
- epidemiology : Elephantiasis, Filarial, India, Lymphedema.
- etiology : Lymphedema.
- methods : Community Health Services.
- therapy : Lymphedema.
- Adolescent, Adult, Aged, Child, Chronic Disease, Cost-Benefit Analysis, Efficiency, Female, Health Expenditures, Humans, Male, Middle Aged, Sick Leave, Young Adult.

Abstract

Lymphatic filariasis afflicts 68 million people in 73 countries, including 17 million persons living with chronic lymphedema. The Global Programme to Eliminate Lymphatic Filariasis aims to stop new infections and to provide care for persons already affected, but morbidity management programs have been initiated in only 24 endemic countries. We examine the economic costs and benefits of alleviating chronic lymphedema and its effects through a simple limb-care program. For Khurda District, Odisha State, India, we estimated lifetime medical costs and earnings losses due to chronic lymphedema and acute dermatolymphangioadenitis (ADLA) with and without a community-based limb-care program. The program would reduce economic costs of lymphedema and ADLA over 60 years by 55%. Savings of US$1,648 for each affected person in the workforce are equivalent to 1,258 days of labor. Per-person savings are more than 130 times the per-person cost of the program. Chronic lymphedema and ADLA impose a substantial physical and economic burden on the population in filariasis-endemic areas. Low-cost programs for lymphedema management based on limb washing and topical medication for infection are effective in reducing the number of ADLA episodes and stopping progression of disabling and disfiguring lymphedema. With reduced disability, people are able to work longer hours, more days per year, and in more strenuous, higher-paying jobs, resulting in an important economic benefit to themselves, their families, and their communities. Mitigating the severity of lymphedema and ADLA also reduces out-of-pocket medical expense.

DOI: 10.4269/ajtmh.16-0286
PubMed: 27573626

Links to Exploration step

pubmed:27573626

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.</title>
<author><name sortKey="Stillwaggon, Eileen" sort="Stillwaggon, Eileen" uniqKey="Stillwaggon E" first="Eileen" last="Stillwaggon">Eileen Stillwaggon</name>
<affiliation><nlm:affiliation>Department of Economics, Gettysburg College, Gettysburg, Pennsylvania. stillwaggon@gettysburg.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sawers, Larry" sort="Sawers, Larry" uniqKey="Sawers L" first="Larry" last="Sawers">Larry Sawers</name>
<affiliation><nlm:affiliation>Department of Economics, American University, Washington, District of Columbia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rout, Jonathan" sort="Rout, Jonathan" uniqKey="Rout J" first="Jonathan" last="Rout">Jonathan Rout</name>
<affiliation><nlm:affiliation>Church's Auxiliary for Social Action (CASA), Bhubaneswar, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Addiss, David" sort="Addiss, David" uniqKey="Addiss D" first="David" last="Addiss">David Addiss</name>
<affiliation><nlm:affiliation>Children Without Worms, Task Force for Global Health, Decatur, Georgia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fox, Leanne" sort="Fox, Leanne" uniqKey="Fox L" first="Leanne" last="Fox">Leanne Fox</name>
<affiliation><nlm:affiliation>Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27573626</idno>
<idno type="pmid">27573626</idno>
<idno type="doi">10.4269/ajtmh.16-0286</idno>
<idno type="wicri:Area/PubMed/Corpus">000648</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000648</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.</title>
<author><name sortKey="Stillwaggon, Eileen" sort="Stillwaggon, Eileen" uniqKey="Stillwaggon E" first="Eileen" last="Stillwaggon">Eileen Stillwaggon</name>
<affiliation><nlm:affiliation>Department of Economics, Gettysburg College, Gettysburg, Pennsylvania. stillwaggon@gettysburg.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sawers, Larry" sort="Sawers, Larry" uniqKey="Sawers L" first="Larry" last="Sawers">Larry Sawers</name>
<affiliation><nlm:affiliation>Department of Economics, American University, Washington, District of Columbia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rout, Jonathan" sort="Rout, Jonathan" uniqKey="Rout J" first="Jonathan" last="Rout">Jonathan Rout</name>
<affiliation><nlm:affiliation>Church's Auxiliary for Social Action (CASA), Bhubaneswar, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Addiss, David" sort="Addiss, David" uniqKey="Addiss D" first="David" last="Addiss">David Addiss</name>
<affiliation><nlm:affiliation>Children Without Worms, Task Force for Global Health, Decatur, Georgia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fox, Leanne" sort="Fox, Leanne" uniqKey="Fox L" first="Leanne" last="Fox">Leanne Fox</name>
<affiliation><nlm:affiliation>Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The American journal of tropical medicine and hygiene</title>
<idno type="eISSN">1476-1645</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Chronic Disease</term>
<term>Community Health Services (economics)</term>
<term>Community Health Services (methods)</term>
<term>Cost-Benefit Analysis</term>
<term>Efficiency</term>
<term>Elephantiasis, Filarial (complications)</term>
<term>Elephantiasis, Filarial (economics)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Endemic Diseases (economics)</term>
<term>Female</term>
<term>Health Expenditures</term>
<term>Humans</term>
<term>India (epidemiology)</term>
<term>Lymphedema (economics)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (therapy)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Sick Leave</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Community Health Services</term>
<term>Elephantiasis, Filarial</term>
<term>Endemic Diseases</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>India</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Community Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Chronic Disease</term>
<term>Cost-Benefit Analysis</term>
<term>Efficiency</term>
<term>Female</term>
<term>Health Expenditures</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Sick Leave</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphatic filariasis afflicts 68 million people in 73 countries, including 17 million persons living with chronic lymphedema. The Global Programme to Eliminate Lymphatic Filariasis aims to stop new infections and to provide care for persons already affected, but morbidity management programs have been initiated in only 24 endemic countries. We examine the economic costs and benefits of alleviating chronic lymphedema and its effects through a simple limb-care program. For Khurda District, Odisha State, India, we estimated lifetime medical costs and earnings losses due to chronic lymphedema and acute dermatolymphangioadenitis (ADLA) with and without a community-based limb-care program. The program would reduce economic costs of lymphedema and ADLA over 60 years by 55%. Savings of US$1,648 for each affected person in the workforce are equivalent to 1,258 days of labor. Per-person savings are more than 130 times the per-person cost of the program. Chronic lymphedema and ADLA impose a substantial physical and economic burden on the population in filariasis-endemic areas. Low-cost programs for lymphedema management based on limb washing and topical medication for infection are effective in reducing the number of ADLA episodes and stopping progression of disabling and disfiguring lymphedema. With reduced disability, people are able to work longer hours, more days per year, and in more strenuous, higher-paying jobs, resulting in an important economic benefit to themselves, their families, and their communities. Mitigating the severity of lymphedema and ADLA also reduces out-of-pocket medical expense.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27573626</PMID>
<DateCreated><Year>2016</Year>
<Month>08</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>05</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>05</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-1645</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>95</Volume>
<Issue>4</Issue>
<PubDate><Year>2016</Year>
<Month>Oct</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>The American journal of tropical medicine and hygiene</Title>
<ISOAbbreviation>Am. J. Trop. Med. Hyg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.</ArticleTitle>
<Pagination><MedlinePgn>877-884</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Lymphatic filariasis afflicts 68 million people in 73 countries, including 17 million persons living with chronic lymphedema. The Global Programme to Eliminate Lymphatic Filariasis aims to stop new infections and to provide care for persons already affected, but morbidity management programs have been initiated in only 24 endemic countries. We examine the economic costs and benefits of alleviating chronic lymphedema and its effects through a simple limb-care program. For Khurda District, Odisha State, India, we estimated lifetime medical costs and earnings losses due to chronic lymphedema and acute dermatolymphangioadenitis (ADLA) with and without a community-based limb-care program. The program would reduce economic costs of lymphedema and ADLA over 60 years by 55%. Savings of US$1,648 for each affected person in the workforce are equivalent to 1,258 days of labor. Per-person savings are more than 130 times the per-person cost of the program. Chronic lymphedema and ADLA impose a substantial physical and economic burden on the population in filariasis-endemic areas. Low-cost programs for lymphedema management based on limb washing and topical medication for infection are effective in reducing the number of ADLA episodes and stopping progression of disabling and disfiguring lymphedema. With reduced disability, people are able to work longer hours, more days per year, and in more strenuous, higher-paying jobs, resulting in an important economic benefit to themselves, their families, and their communities. Mitigating the severity of lymphedema and ADLA also reduces out-of-pocket medical expense.</AbstractText>
<CopyrightInformation>© The American Society of Tropical Medicine and Hygiene.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stillwaggon</LastName>
<ForeName>Eileen</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Economics, Gettysburg College, Gettysburg, Pennsylvania. stillwaggon@gettysburg.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sawers</LastName>
<ForeName>Larry</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Economics, American University, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rout</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Church's Auxiliary for Social Action (CASA), Bhubaneswar, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Addiss</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Children Without Worms, Task Force for Global Health, Decatur, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fox</LastName>
<ForeName>LeAnne</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>08</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Trop Med Hyg</MedlineTA>
<NlmUniqueID>0370507</NlmUniqueID>
<ISSNLinking>0002-9637</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2013 Sep;107(9):566-77</RefSource>
<PMID Version="1">23832181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Commun Dis. 2008 Jun;40(2):101-9</RefSource>
<PMID Version="1">19301694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2004 Nov 19;79(47):417-24</RefSource>
<PMID Version="1">15595525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 1999 Jan;4(1):19-25</RefSource>
<PMID Version="1">10203169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Southeast Asian J Trop Med Public Health. 1995 Jun;26(2):301-5</RefSource>
<PMID Version="1">8629065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Sep 11;8(9):e3140</RefSource>
<PMID Version="1">25211334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2003 Jan;8(1):56-9</RefSource>
<PMID Version="1">12535251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2002 Sep;7(9):763-6</RefSource>
<PMID Version="1">12225507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010 Jun 01;4(6):e708</RefSource>
<PMID Version="1">20532228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2006 May;11(5):712-7</RefSource>
<PMID Version="1">16640624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2014 Sep 19;89(38):409-18</RefSource>
<PMID Version="1">25243263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Low Extrem Wounds. 2012 Mar;11(1):5-9</RefSource>
<PMID Version="1">22354118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010 Apr 20;4(4):e668</RefSource>
<PMID Version="1">20422031</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3319</RefSource>
<PMID Version="1">25412180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):639-43</RefSource>
<PMID Version="1">9015500</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2013 Jul;89(1):16-22</RefSource>
<PMID Version="1">23690550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):669-70</RefSource>
<PMID Version="1">9015511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2005 May;72 (5):642-8</RefSource>
<PMID Version="1">15891143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):413-7</RefSource>
<PMID Version="1">10674092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Public Health. 1999 Apr-Jun;43(2):58-63</RefSource>
<PMID Version="1">11243067</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2001 Sep;65(3):204-7</RefSource>
<PMID Version="1">11561705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2015 Sep 18;90(38):489-504</RefSource>
<PMID Version="1">26387149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2011 Sep;120 Suppl 1:S55-61</RefSource>
<PMID Version="1">21470557</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Glob Infect Dis. 2011 Jul;3(3):227-32</RefSource>
<PMID Version="1">21887053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Public Health. 2005 May 19;5:50</RefSource>
<PMID Version="1">15904537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2004 Oct;98(7):685-96</RefSource>
<PMID Version="1">15521106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2002 Apr;82(1):31-8</RefSource>
<PMID Version="1">11904101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(3):e2100</RefSource>
<PMID Version="1">23516648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2011 Sep;120 Suppl 1:S69-75</RefSource>
<PMID Version="1">20974106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004171</RefSource>
<PMID Version="1">26496129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2007 Sep;101(6):487-97</RefSource>
<PMID Version="1">17716431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):594-6</RefSource>
<PMID Version="1">11198637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Korean J Parasitol. 2008 Sep;46(3):119-25</RefSource>
<PMID Version="1">18830049</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1998 Jul;92(5):587-94</RefSource>
<PMID Version="1">9797832</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 1996 Jun;54(6):591-5</RefSource>
<PMID Version="1">8686777</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 1998 Feb;3(2):108-15</RefSource>
<PMID Version="1">9537272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):255-9</RefSource>
<PMID Version="1">1887487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Dermatol. 2006 May;154(5):933-41</RefSource>
<PMID Version="1">16634898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2003 Dec;8(12):1102-9</RefSource>
<PMID Version="1">14641845</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2000 Jun;94(4):353-64</RefSource>
<PMID Version="1">10945045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):260-4</RefSource>
<PMID Version="1">1887488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1999 Jun;93(4):367-77</RefSource>
<PMID Version="1">10656038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2011 Jan;105(1):58-60</RefSource>
<PMID Version="1">20850849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2013 Jun;126(3):198-204</RefSource>
<PMID Version="1">23499714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitol Today. 2000 Jun;16(6):251-3</RefSource>
<PMID Version="1">10827432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2016 Aug 22;10(8):e0004917</RefSource>
<PMID Version="1">27548382</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2007 Feb 15;6:2</RefSource>
<PMID Version="1">17302976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 1990 May;91:200-7</RefSource>
<PMID Version="1">2397942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 1982 Jun;75:813-5</RefSource>
<PMID Version="1">7129551</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2011 Dec 16;86(51-52):581-5</RefSource>
<PMID Version="1">22191103</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2000 Feb 25;75(1):19-28</RefSource>
<PMID Version="1">10708003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neth J Med. 2012 Jun;70(5):210-4</RefSource>
<PMID Version="1">22744921</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003153" MajorTopicYN="N">Community Health Services</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004526" MajorTopicYN="N">Efficiency</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005102" MajorTopicYN="Y">Health Expenditures</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N">India</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018582" MajorTopicYN="Y">Sick Leave</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>04</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>07</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>5</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27573626</ArticleId>
<ArticleId IdType="pii">ajtmh.16-0286</ArticleId>
<ArticleId IdType="doi">10.4269/ajtmh.16-0286</ArticleId>
<ArticleId IdType="pmc">PMC5062793</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000648 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000648 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:27573626
   |texte=   Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:27573626" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki